Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Given that the majority of the health benefits and cost savings from quitting are likely to be experienced post trial, the implications for quality-adjusted life years (QALYs) and future costs will be modelled over the lifetime using an individual-level simulation model which considers smoking intensity, future smoking behaviour and cessation attempts and the estimated impacts on lung cancer, chronic obstructive pulmonary disease, myocardial infarctions and stroke and the cost per QALY will be estimated
Assessing outcome in smoking cessation studies
The development of candidate modified risk tobacco products (cMRTP) is aimed at providing smokers who will not quit with alternatives to cigarettes that present less risk of harm and smoking-related disease
When the beer is gone, resume breathing, and bask in the glory of your achievement
Vintage-style Full Gloss Nitrocellulose Lacquer Finish
I live in the past, the present and the future!
